U. Weidle

发表

TGF-β-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen

P. Steinlein, V. Horejsi, V. Leksa, 2005, Journal of Cell Science.

Epigenetic modification of transgenes under the control of the mouse mammary tumor virus LTR: tissue-dependent influence on transcription of the transgenes.

G. Brem, U. Weidle, G. Betzl, 1996, Biological chemistry.

Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment.

U. Weidle, A. Grossmann, 2000, Anticancer research.

Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers

V. Castronovo, U. Weidle, D. Waltregny, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.

U. Weidle, K. Danø, G. Høyer-Hansen, 2001, The Biochemical journal.

Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.

U. Weidle, K. Danø, G. Høyer-Hansen, 2001, The Biochemical journal.

Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1–2, and melanocytic cell transformation

U. Weidle, W. Lamers, M. Alders, 2002, The Journal of pathology.

Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.

U. Weidle, M. Daha, H. Burtscher, 2012, The Journal of investigative dermatology.

Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancers.

U. Weidle, S. Alberti, N. Fersis, 2009, Anticancer research.

Investigation of prevalence and regulation of expression of progression associated protein (PAP).

A. Gnirke, U. Weidle, 1998, Anticancer research.

β1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts

K. Wennerberg, H. Krell, U. Weidle, 1999, Oncogene.

Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

U. Weidle, V. V. van Hinsbergh, P. Koolwijk, 1999, The American journal of pathology.

The XAGE family of cancer/testis‐associated genes: Alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma

U. Weidle, D. Ruiter, G. V. van Muijen, 2002, International journal of cancer.

Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

V. Castronovo, L. de Leval, U. Weidle, 2004, The American journal of pathology.

ALCAM/CD166: cancer-related issues.

U. Weidle, S. Klostermann, G. Swart, 2010, Cancer genomics & proteomics.

The emerging role of new protein scaffold-based agents for treatment of cancer.

Guy Georges, Ulrich Brinkmann, U. Brinkmann, 2013, Cancer genomics & proteomics.

Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family.

U. Weidle, N. Brünner, L. Engelholm, 1997, Anticancer research.

Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression

P. Altevogt, A. Krüger, J. Ramser, 2011, PloS one.

Short Communication Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin

U. Weidle, J. Oord, H. Bloemers, 2000 .

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

P. Quax, H. Verspaget, U. Weidle, 1994, The American journal of pathology.

Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma

U. Brinkmann, U. Weidle, J. Niewoehner, 2022, Cancer Genomics & Proteomics.

LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation

E. Kremmer, M. Ueffing, U. Weidle, 2013, Journal of Cell Science.

TCR-MHC/peptide interaction: prospects for new anti-tumoral agents.

U. Weidle, G. Georges, G. Tiefenthaler, 2014, Cancer genomics & proteomics.

MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models

U. Weidle, A. Nopora, Adam Nopora, 2022, Cancer Genomics & Proteomics.

An Upstream Open Reading Frame Regulates LST1 Expression during Monocyte Differentiation

U. Weidle, K. N. Diakopoulos, E. Weiss, 2014, PloS one.

β1 Integrin Is Essential for Teratoma Growth and Angiogenesis

H. Krell, U. Weidle, R. Fässler, 1997, The Journal of cell biology.

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

P. Carmeliet, J. Foidart, A. Noël, 2001, The Journal of cell biology.

Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.

U. Weidle, M. Ploug, K. Danø, 1993, The Journal of biological chemistry.

Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides

U. Weidle, M. Schmitt, H. Kessler, 1997, Biological chemistry.

Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.

U. Weidle, M. Schmitt, H. Kessler, 1996, European journal of biochemistry.

Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)

U. Weidle, M. Schmitt, P. Rettenberger, 1994, FEBS letters.

Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer

U. Weidle, A. Nopora, Adam Nopora, 2022, AntiCancer Research.

Urokinase Plasminogen Activator Receptor, ~2-Integrins, and Src-kinases within a Single Receptor Complex of Human Monocytes By Jan Bohuslav, .1 V~clav Ho~ej~f,~ t Cornelia Hansmann,*

W. Knapp, U. Weidle, H. Stockinger, 1995 .

Identification of CRASH, a gene deregulated in gynecological tumors.

R. Zeillinger, U. Weidle, S. Kaul, 2004, International journal of oncology.

Chimeric interleukin 2 receptor alpha chain antibody derivatives with fused mu and gamma chains permit improved recruitment of effector functions.

U. Weidle, B. Kaluza, Y. Jacques, 1995, Molecular immunology.

High-copy expression vector based on amplification-promoting sequences.

U. Weidle, F. Grummt, C. Hemann, 1994, DNA and cell biology.

Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs.

H. Lenz, G. Brem, U. Weidle, 1991, Gene.

Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis.

F. Jänicke, U. Weidle, M. Schmitt, 1995, Journal of obstetrics and gynaecology.

Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors

U. Weidle, F. Birzele, G. Tiefenthaler, 2018, Cancer Genomics & Proteomics.

Identification of THW, a putative new tumor suppressor gene.

U. Weidle, S. Klostermann, G. V. van Muijen, 2000, Anticancer research.

Urokinase receptor antagonists: novel agents for the treatment of cancer.

U. Weidle, B. König, 1998, Expert opinion on investigational drugs.

Expression of the human urokinase‐type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: Purification of the recombinant proteins and generation of polyclonal antibodies in chicken

U. Weidle, M. Schmitt, V. Magdolen, 1995, Electrophoresis.

Synthesis and functional characterization of a recombinant monoclonal antibody directed against the alpha-chain of the human interleukin-2 receptor.

H. Lenz, O. Majdic, W. Knapp, 1991, Gene.

L1-CAM as a target for treatment of cancer with monoclonal antibodies.

U. Weidle, S. Klostermann, Daniela Eggle, 2009, Anticancer research.

Ectopic expression of DICE1 suppresses tumor cell growth.

U. Weidle, P. Wieacker, I. Wieland, 2004, Oncology reports.

Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma

U. Weidle, G. V. van Muijen, D. Ruiter, 2001, Melanoma research.

Components of the plasminogen activation system in uveal melanoma—a clinico‐pathological study

P. Quax, H. Verspaget, U. Weidle, 1995, The Journal of pathology.

Expression profiling of MMA‐1a and splice variant MMA‐1b: New cancer/testis antigens identified in human melanoma

U. Weidle, G. V. van Muijen, D. Ruiter, 2002, International journal of cancer.

Amplified expression constructs for human tissue-type plasminogen activator in Chinese hamster ovary cells: instability in the absence of selective pressure.

J. Wienberg, U. Weidle, P. Buckel, 1988, Gene.

Establishment of a temperature-inducible cell line for human plasminogen activator (tissue-type) by transfection of monkey cells with expression constructs.

U. Weidle, P. Buckel, A. Lawetzky, 1987, Gene.

Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism

U. Weidle, F. Birzele, Fabian Birzele, 2022, Cancer Genomics & Proteomics.

Expression of recombinant antibody and secreted alkaline phosphatase in mammalian cells. Influence of cell line and culture system upon production kinetics

J. B. Griffiths, P. Alves, M. Carrondo, 1994, Applied Microbiology and Biotechnology.

Integrin Is Essential for Teratoma Growth and Angiogenesis

H. Krell, U. Weidle, R. Fässler, 1997 .

Intracellular proteins displayed on the surface of tumor cells as targets for therapeutic intervention with antibody-related agents.

U. Weidle, D. Maisel, S. Klostermann, 2011, Cancer genomics & proteomics.

Complex expression pattern of the TNF region gene LST1 through differential regulation, initiation, and alternative splicing.

U. Weidle, S. Maier, E. Weiss, 1997, Genomics.

Fast-sorting system for cells with high-copy-number expression vectors and its use for the modulation of CML cells.

H. Lipps, U. Weidle, F. Grummt, 1998, Advances in experimental medicine and biology.

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models.

U. Weidle, A. Nopora, Adam Nopora, 2021, Cancer genomics & proteomics.

Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon.

U. Brinkmann, U. Weidle, G. Georges, 2012, Cancer genomics & proteomics.

Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line

M. Zöller, U. Weidle, M. Rio, 2005, International journal of cancer.

Ablative and Anti-Invasive Therapy of Cancer

U. Weidle, 1998, Oncology Research and Treatment.

Loss of heterozygosity of gene THW is frequently found in melanoma metastases.

U. Weidle, G. V. van Muijen, M. V. van Dijk, 2001, Anticancer research.

Control of cell growth by c-Myc in the absence of cell division

U. Weidle, A. Polack, D. Eick, 1999, Current Biology.

Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression.

U. Weidle, J. Verheijen, G. V. van Muijen, 1996, Cancer research.

A protease-hypersensitive deletion derivative of human tissue-type plasminogen activator.

U. Weidle, R. Mattes, P. Buckel, 1988, Gene.

Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts.

J. Foidart, A. Noël, C. Munaut, 1995, Invasion & metastasis.

Molecular Basis for the Homophilic Activated Leukocyte Cell Adhesion Molecule (ALCAM)-ALCAM Interaction*

C. Figdor, U. Weidle, L. V. van Kempen, 2001, The Journal of Biological Chemistry.

Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line

U. Weidle, D. Eick, H. Burtscher, 2005, Oncogene.

The transcriptional program of a human B cell line in response to Myc.

U. Weidle, A. Polack, D. Eick, 2001, Nucleic acids research.

Expression of heterobispecific antibodies by genes transfected into producer hybridoma cells.

H. Lenz, U. Weidle, 1990, Gene.

Construction of a bispecific antibody reacting with the alpha- and beta-chains of the human IL-2 receptor. High affinity cross-linking and high anti-proliferative efficiency.

U. Weidle, B. Kaluza, Y. Jacques, 1993, Journal of immunology.

A new expression system for mammalian cells based on putative replicator sequences of the mouse and a truncated thymidine kinase gene.

U. Weidle, F. Grummt, P. Buckel, 1988, Gene.

Chimerization of antibodies by isolation of rearranged genomic variable regions by the polymerase chain reaction.

W. Weissenhorn, U. Weidle, E. Weiss, 1991, Gene.

Involvement of PA/plasmin system in the processing of pro‐MMP‐9 and in the second step of pro‐MMP‐2 activation

J. Foidart, A. Noël, H. Krell, 1997, FEBS letters.

The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies

Nils Brünner, Robert D. Gerard, Geert Carmeliet, 2001 .

Localization of the components of the plasminogen activation system in cutaneous melanocytic lesions — a minireview

U. Weidle, D. Ruiter, G. Muijen, 1996 .

Identification of URIM, a novel gene up-regulated in metastasis.

U. Weidle, S. Klostermann, G. V. van Muijen, 1999, Anticancer research.

Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells.

H. Lenz, U. Weidle, R. Mattes, 1987, Gene.

Long Non-coding RNAs and their Role in Metastasis.

U. Weidle, F. Birzele, R. Rüger, 2017, Cancer genomics & proteomics.

Assembly of an antibody and its derived antibody fragment inNicotiana andArabidopsis

M. Montagu, A. Depicker, U. Weidle, 1993, Transgenic Research.

Expression of antibody cDNA in murine myeloma cells: possible involvement of additional regulatory elements in transcription of immunoglobulin genes.

U. Weidle, P. Buckel, S. Koch, 1987, Gene.

The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.

U. Weidle, D. Ruiter, G. V. van Muijen, 2003, Gene.

Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models

U. Weidle, A. Nopora, Adam Nopora, 2020, Cancer Genomics & Proteomics.

Upregulation of Trop-2 quantitatively stimulates human cancer growth

R. Tripaldi, U. Weidle, S. Alberti, 2013, Oncogene.

The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

U. Brinkmann, U. Weidle, Corinna Hintermair, 2018, Cancer genomics & proteomics.

Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.

U. Weidle, D. Eick, Franziska Hampel, 2009, Blood.

Antigens CTp11, a Novel Member of the Family of Human Cancer/Testis

U. Weidle, D. Ruiter, I. Cornelissen, 1999 .

Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

U. Weidle, F. Birzele, A. Nopora, 2018, Cancer genomics & proteomics.

Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma

U. Brinkmann, U. Weidle, Simon Ausländer, 2020, Cancer Genomics & Proteomics.

MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets

U. Weidle, A. Nopora, Adam Nopora, 2021, Cancer Genomics & Proteomics.

microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models

U. Brinkmann, U. Weidle, Simon Auslaender, 2020, Cancer Genomics & Proteomics.

Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy

U. Brinkmann, U. Weidle, F. Birzele, 2021, AntiCancer Research.

A role for c-Myc in the regulation of ribosomal RNA processing.

Michael Hölzel, Dirk Eick, Helmut Burtscher, 2003, Nucleic acids research.

The role of MAPK pathways in the action of chemotherapeutic drugs.

W. Kolch, U. Weidle, S. Boldt, 2002, Carcinogenesis.

Molecular Analysis of Two Mammary Carcinoma Cell Lines at the Transcriptional Level as a Model System for Progression of Breast Cancer

N. Brünner, U. Weidle, S. Schiemann, 1998, Clinical & Experimental Metastasis.

The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.

W. Kolch, U. Weidle, S. Boldt, 2003, Experimental cell research.

Proteases as activators for cytotoxic prodrugs in antitumor therapy.

U. Weidle, G. Georges, G. Tiefenthaler, 2014, Cancer genomics & proteomics.

Molecular characterization of the DICE1 (DDX26) tumor suppressor gene in lung carcinoma cells.

U. Weidle, A. Röpke, P. Wieacker, 2001, Oncology research.

Isolation of DICE1: A gene frequently affected by LOH and downregulated in lung carcinomas

K. Arden, L. Klein-Hitpass, U. Weidle, 1999, Oncogene.

Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention.

U. Weidle, F. Birzele, R. Rüger, 2016, Cancer genomics & proteomics.

Establishment of stable mouse myeloma cells constitutively secreting human tissue-type plasminogen activator.

U. Weidle, P. Buckel, 1987, Gene.

The Multiple Roles of Exosomes in Metastasis.

U. Weidle, F. Birzele, R. Rüger, 2017, Cancer genomics & proteomics.

A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells

U. Weidle, H. Hauser, H. Kollmus, 1993, Journal of virology.

Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.

U. Weidle, F. Birzele, Fabian Birzele, 2021, Cancer diagnosis & prognosis.

Transactivation of the HIV promoter by Tat can be estimated by a bacterial blue-white color system.

U. Weidle, S. Rusconi, E. Wöllisch, 1990, Gene.

Functional topology of human tissue-type plasminogen activator: characterization of two deletion derivatives and of a duplication derivative.

U. Weidle, R. Mattes, P. Buckel, 1989, Gene.

The intriguing options of multispecific antibody formats for treatment of cancer.

Guy Georges, Ulrich Brinkmann, U. Brinkmann, 2013, Cancer genomics & proteomics.

Molecular targets and pathways involved in liver metastasis of colorectal cancer

A. Krüger, U. Weidle, F. Birzele, 2015, Clinical & Experimental Metastasis.

Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.

U. Brinkmann, U. Weidle, G. Georges, 2014, Cancer genomics & proteomics.

A novel type of unstable homogeneously staining region with a head-to-tail arrangement: spontaneous decay and reintegration of DNA elements into a plethora of new chromosomal sites.

J. Wienberg, U. Weidle, F. Grummt, 1995, Cytogenetics and cell genetics.

Distinct mouse DNA sequences enable establishment and persistence of plasmid DNA polymers in mouse cells.

J. Wienberg, M. Wegner, U. Weidle, 1989, Nucleic acids research.

Synthetic lethality-based targets for discovery of new cancer therapeutics.

U. Weidle, D. Maisel, D. Eick, 2011, Cancer genomics & proteomics.

Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

U. Weidle, F. Birzele, G. Kollmorgen, 2016, Cancer genomics & proteomics.

Molecular Basis of Lung Tropism of Metastasis.

U. Weidle, F. Birzele, R. Rüger, 2016, Cancer genomics & proteomics.

Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models

U. Weidle, F. Birzele, A. Nopora, 2019, Cancer Genomics & Proteomics.

MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer

U. Weidle, F. Birzele, A. Nopora, 2019, Cancer Genomics & Proteomics.

The MMA1 gene family of cancer‐testis antigens has multiple alternative splice variants: Characterization of their expression profile, the genomic organization, and transcript properties

U. Weidle, G. V. van Muijen, D. Ruiter, 2005, Genes, chromosomes & cancer.

TETRANECTIN AND PLASMIN/PLASMINOGEN ARE SIMILARLY DISTRIBUTED AT THE INVASIVE FRONT OF CUTANEOUS MELANOMA LESIONS

H. Verspaget, U. Weidle, E. Bröcker, 1996, The Journal of pathology.

Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes

O. Majdic, W. Knapp, U. Weidle, 1995, The Journal of experimental medicine.

The Blood-Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological Diseases.

Jens Niewöhner, U. Weidle, Ulrich H Weidle, 2015, Cancer genomics & proteomics.

CTp11, a novel member of the family of human cancer/testis antigens.

U. Weidle, D. Ruiter, G. V. van Muijen, 1999, Cancer research.

Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis.

P Bork, M Schwirzke, A. Gnirke, 1998, Anticancer research.

Flow Cytofluorometric Analysis of the Urokinase Receptor (uPAR) on Tumor Cells by Fluorescent uPA-ligand or Monoclonal Antibody #3936

F. Jänicke, U. Weidle, M. Schmitt, 1992 .

Differential splicing generates new transmembrane receptor and extracellular matrix-related targets for antibody-based therapy of cancer.

U. Weidle, D. Maisel, M. Schmitt, 2011, Cancer genomics & proteomics.

Genetically engineered fusion proteins for treatment of cancer.

U. Brinkmann, U. Weidle, G. Georges, 2012, Cancer genomics & proteomics.

Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells

U. Weidle, B. Holzmann, H. Weighardt, 2004, Clinical & Experimental Metastasis.

The urokinase/urokinase receptor system A new target for cancer therapy?

S. Hoehl, U. Weidle, M. Schmitt, 1994 .

Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay

U. Weidle, M. Schmitt, H. Kessler, 1997 .

A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.

U. Weidle, F. Lottspeich, M. Kramer, 1995, Biological chemistry Hoppe-Seyler.

Expression of urokinase-type plasminogen-activator (upa) and its receptor (upar) in human ovarian-cancer cells and in-vitro invasion capacity.

R. Kreienberg, U. Weidle, M. Schmitt, 1994, International journal of oncology.

Identification of Genes Associated with the Invasive Status of Human Mammary Carcinoma Cell Lines by Transcriptional Profiling

R. Zeillinger, U. Weidle, V. Evtimova, 2003, Tumor Biology.

The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs

U. Brinkmann, U. Weidle, F. Birzele, 2018, Cancer Genomics & Proteomics.

Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer

M. Pedriali, P. Querzoli, R. Tripaldi, 2021, Neoplasia.

microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis

U. Weidle, F. Birzele, A. Nopora, 2021, Cancer Genomics & Proteomics.

Characterization of XAGE‐1b, a short major transcript of cancer/testis‐associated gene XAGE‐1, induced in melanoma metastasis

A. D. den Hollander, U. Weidle, G. V. van Muijen, 2002, International journal of cancer.

Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical In Vivo Models

U. Brinkmann, U. Weidle, F. Birzele, 2021, Cancer Genomics & Proteomics.

The translational potential for target validation and therapy using intracellular antibodies in oncology.

U. Brinkmann, U. Weidle, D. Maisel, 2013, Cancer genomics & proteomics.

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays

U. Weidle, T. V. van Kuppevelt, G. V. van Muijen, 2005, British Journal of Cancer.

Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy.

P. Quax, U. Weidle, M. Ploug, 1994, Annales de biologie clinique.

Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay.

H. Nielsen, U. Weidle, M. Ploug, 1994, Journal of immunological methods.

Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.

U. Weidle, D. Ruiter, R. D. de Waal, 1997, The American journal of pathology.

Cancer-related issues of CD147.

Hannes Stockinger, Werner Scheuer, Daniela Eggle, 2010, Cancer genomics & proteomics.

Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens.

R. Zeillinger, U. Weidle, V. Möbus, 2005, Oncology reports.

Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis.

Helmut Burtscher, U. Weidle, H. Burtscher, 2002, Anticancer research.

Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.

U. Weidle, G. V. van Muijen, M. Jarsch, 2001, Anticancer research.

MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance

U. Brinkmann, U. Weidle, D. Schmid, 2019, Cancer Genomics & Proteomics.

TM7XN1, a novel human EGF‐TM7‐like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential 1

U. Weidle, G. V. van Muijen, D. Ruiter, 1999, FEBS letters.

The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration*

V. Leksa, S. Godár, U. Weidle, 2002, The Journal of Biological Chemistry.

Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.

M. Herlyn, C. Garbe, U. Weidle, 2004, The Journal of investigative dermatology.

A general method for chimerization of monoclonal antibodies by inverse polymerase chain reaction which conserves authentic N-terminal sequences.

U. Weidle, G. Betzl, B. Kaluza, 1992, Gene.

Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays

U. Weidle, H. Burtscher, G. V. van Muijen, 2002, Melanoma research.

LST1: A multifunctional gene encoded in the MHC class III region.

U. Weidle, F. Birzele, E. Weiss, 2018, Immunobiology.

Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.

D. Tarin, U. Weidle, H. Burtscher, 2002, Anticancer research.

M6P/IGFII‐receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor‐β1

S. Godár, U. Weidle, B. Binder, 1999, European journal of immunology.

M6P/IGFII‐receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor‐β1

S. Godár, U. Weidle, B. Binder, 1999 .

Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.

J. J. van den Oord, U. Weidle, G. V. van Muijen, 2000, The American journal of pathology.

SMAGP, a new small trans-membrane glycoprotein altered in cancer

U. Weidle, M. Rio, N. Tarbé, 2004, Oncogene.

Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets

U. Weidle, A. Nopora, Adam Nopora, 2023, Cancer Genomics & Proteomics.

LKW, a Putative Dual-specificity Kinase which is Down-regulated in Several Invasive Systems.

U. Weidle, T. Gress, M. Buchholz, 2004, Cancer genomics & proteomics.

Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer.

A. Krüger, U. Weidle, S. Klostermann, 2010, Cancer genomics & proteomics.

Molecular Mechanisms of Bone Metastasis.

U. Weidle, F. Birzele, R. Rüger, 2016, Cancer genomics & proteomics.

Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models

U. Brinkmann, U. Weidle, Hung-En Hsia, 2023, Cancer Genomics & Proteomics.

Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in Preclinical In Vivo Models

U. Weidle, F. Birzele, Fabian Birzele, 2023, Cancer Genomics & Proteomics.

Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line.

U. Weidle, Ulrich H Weidle, Robert de Lange, 2003, Anticancer research.

Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).

F. Jänicke, U. Weidle, M. Schmitt, 1992, Biochemical Society Transactions.

Kringle 1 domain of human tissue-type plasminogen activator is a functional module mediating fibrinogen-stimulated plasminogenolytic activity.

U. Weidle, A. Stern, 1990, Gene.

Tumor-antigen-binding bispecific antibodies for cancer treatment.

U. Brinkmann, R. Kontermann, U. Weidle, 2014, Seminars in oncology.

Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.

D. Tarin, U. Weidle, H. Burtscher, 2001, Anticancer research.

New genes potentially involved in breast cancer metastasis.

A. Gnirke, U. Weidle, S. Schiemann, 1999, Anticancer research.

Molecular targets and pathways involved in liver metastasis of colorectal cancer

A. Krüger, U. Weidle, F. Birzele, 2015, Clinical & Experimental Metastasis.

Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumor model reveals metastasis-associated genes.

U. Weidle, H. Burtscher, M. Jarsch, 2001, Anticancer research.

Lymphocites t tumoricides

U. Weidle, H. Jungfer, W. Albert, 1994 .

M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.

S. Godár, U. Weidle, V. Hořejší, 1999, European journal of immunology.

Identification of two estrogen regulated genes associated with growth regulation of human breast cancer

P. Briand, U. Weidle, N. Brünner, 2001, Molecular and Cellular Endocrinology.

Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities.

U. Weidle, Fabian Birzele, 2023, Cancer genomics & proteomics.

CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention

U. Weidle, Adam Nopora, 2024, Cancer Genomics & Proteomics.

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention

U. Weidle, Fabian Birzele, 2024, Cancer Genomics & Proteomics.